News
bioMérieux, a world leader in the field of in vitro diagnostics, signed in November 2024 a Sale and Purchase Agreement (SPA) to acquire Neoprospecta. This company, based in Florianopolis, Brazil, develops and markets innovative user-friendly data and genomics solutions for augmenting quality assurance programs and improve microbiological risk prevention in food and pharma industries.
Swipe to discover more
-
Third-Quarter 2024 Business Review
bioMérieux, a world leader in the field of in vitro diagnostics, today releases its business review for the nine months ended September 30, 2024: Consolidated sales amounted to €2,871 million, representing an organic growth of +10.3% at constant exchange rates and scope of consolidation. -
Frederick Novy: The Search for Exact Truths in the Laboratory
Frederick Novy had an extensive career pioneering the development of microbiology as an academic discipline and field of research, and he assisted in setting the framework for modern medical science. Before his time, microbiology was focused on disease prevention, but F.Novy made extensive strides to further the understanding of microbes at their deepest levels. Through research, discipline, and teaching, he persuaded others do to the same. “F.Novy was among the last survivors of that eager group of young American biologists and hygienists who journeyed to Europe in the 1880s to work in the laboratories of Louis Pasteur and Robert Koch and learn the fundamentals of the new science of bacteriology at first hand,” noted biographer Esmond R. Long. -
Canada's First Center of Excellence in the Fight Against Antimicrobial Resistance
On November 11, 2024, the Université de Sherbrooke (UdeS), the Centre intégré universitaire de santé et de services sociaux de l'Estrie - Centre hospitalier universitaire de Sherbrooke (CIUSSS de l'Estrie - CHUS) and bioMérieux, a world leader in the field of in vitro diagnostics, announce a three-year agreement to create a Canadian center of excellence dedicated to the fight against antimicrobial resistance and antibiotic stewardship.
Enabling Decision-Making
- ANTIMICROBIAL STEWARDSHIP
- SEPSIS
- FOOD SAFETY & QUALITY
- PHARMA QUALITY CONTROL
- COVID-19
- ANTIMICROBIAL STEWARDSHIP
- SEPSIS
- FOOD SAFETY & QUALITY
- PHARMA QUALITY CONTROL
- COVID-19